| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
27,348 |
20,120 |
$2.24M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
30,154 |
19,695 |
$1.86M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
8,158 |
5,780 |
$301K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,288 |
1,870 |
$256K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
4,974 |
3,174 |
$78K |
| 99215 |
Prolong outpt/office vis |
652 |
480 |
$75K |
| 90682 |
|
1,553 |
1,255 |
$70K |
| 99385 |
|
553 |
460 |
$56K |
| 99386 |
|
339 |
267 |
$36K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,599 |
1,556 |
$30K |
| 99406 |
|
2,219 |
1,772 |
$26K |
| 99407 |
|
1,130 |
865 |
$25K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
705 |
565 |
$25K |
| 96160 |
|
6,957 |
5,556 |
$23K |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
5,683 |
4,697 |
$23K |
| 99050 |
|
2,335 |
1,773 |
$16K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,637 |
1,261 |
$14K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
107 |
92 |
$12K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
83 |
70 |
$6K |
| 96127 |
|
1,484 |
1,143 |
$6K |
| 99051 |
|
515 |
438 |
$5K |
| 0001A |
|
151 |
131 |
$5K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
41 |
38 |
$4K |
| 99495 |
|
35 |
26 |
$4K |
| 99442 |
|
382 |
333 |
$4K |
| 93000 |
|
321 |
265 |
$4K |
| 0124A |
|
192 |
128 |
$4K |
| G0008 |
Administration of influenza virus vaccine |
370 |
316 |
$4K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
127 |
118 |
$3K |
| 0004A |
|
121 |
98 |
$3K |
| 0011A |
|
81 |
74 |
$3K |
| 99441 |
|
566 |
448 |
$2K |
| 91300 |
|
393 |
332 |
$2K |
| 99382 |
|
15 |
15 |
$2K |
| 0003A |
|
58 |
55 |
$2K |
| 90662 |
|
134 |
98 |
$2K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
332 |
204 |
$1K |
| J1071 |
Injection, testosterone cypionate, 1 mg |
308 |
122 |
$1K |
| 0013A |
|
48 |
41 |
$1K |
| 90686 |
|
92 |
84 |
$1K |
| 82962 |
|
208 |
173 |
$1K |
| 91301 |
|
118 |
106 |
$775.02 |
| 0064A |
|
23 |
21 |
$772.00 |
| 0134A |
|
27 |
17 |
$680.00 |
| 90688 |
|
31 |
29 |
$546.08 |
| 91312 |
|
148 |
104 |
$506.43 |
| H0050 |
Alcohol and/or drug services, brief intervention, per 15 minutes |
23 |
16 |
$368.00 |
| 91306 |
|
20 |
20 |
$317.23 |
| 83655 |
|
27 |
27 |
$297.25 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
38 |
27 |
$243.12 |
| 99443 |
|
22 |
19 |
$199.88 |
| G2061 |
Qualified nonphysician healthcare professional online assessment and management service, for an established patient, for up to seven days, cumulative time during the 7 days; 5-10 minutes |
48 |
45 |
$184.10 |
| 3074F |
|
2,541 |
2,051 |
$145.51 |
| G0396 |
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes |
41 |
29 |
$137.22 |
| 3288F |
|
18 |
16 |
$102.16 |
| 3075F |
|
674 |
599 |
$100.00 |
| 80053 |
Comprehensive metabolic panel |
21 |
18 |
$52.62 |
| 80061 |
Lipid panel |
16 |
13 |
$50.13 |
| 91313 |
|
28 |
17 |
$49.14 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
16 |
13 |
$48.38 |
| 81000 |
|
18 |
16 |
$22.48 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
16 |
13 |
$20.06 |
| 3079F |
|
1,119 |
966 |
$13.50 |
| 3078F |
|
2,413 |
1,964 |
$9.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13 |
12 |
$0.08 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
460 |
415 |
$0.00 |
| H0049 |
Alcohol and/or drug screening |
74 |
71 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
28 |
25 |
$0.00 |
| INVCD |
|
35 |
35 |
$0.00 |